Unchanged density of caudate nucleus dopamine uptake sites in depressed suicide victims

Journal of Neural Transmission

Volumn 104, Issue 11-12, 1997, Pages 1353-1360

  Allard, P ^a   Norlen M ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

3H WIN 35,428; Caudate nucleus; Dopamine uptake sites; Human brain; Suicidal depression

Indexed keywords

3BETA (4 FLUOROPHENYL) 2BETA TROPANECARBOXYLIC ACID METHYL ESTER; DOPAMINE;

ADULT; AGED; ARTICLE; AUTOPSY; CAUDATE NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DOPAMINE BRAIN LEVEL; DOPAMINE UPTAKE; DOPAMINERGIC SYSTEM; FEMALE; HUMAN; LIGAND BINDING; MALE; PRIORITY JOURNAL; SUICIDE;

ADULT; AGED; AGED, 80 AND OVER; CAUDATE NUCLEUS; COCAINE; DEPRESSIVE DISORDER; DOPAMINE; DOPAMINE UPTAKE INHIBITORS; FEMALE; HUMANS; LIGANDS; MALE; MIDDLE AGED; RECEPTORS, DOPAMINE; SUICIDE;

EID: 0031435712     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01294736     Document Type: Article

References (28)

1. 3H]GBR-12935 binding in the human frontal cortex - Reply. J Neurochem 63: 1182-1183
2. Allard P (1995) Questions about the dopamine terminals in human frontal cortex - Reply. J Neurochem 64: 1902-1903
3. 3H]GBR-12935 in Alzheimer's disease. Eur Neurol 30: 181-185
4. 3H]GBR-12935 binding after chronic treatment with dopamine active drugs. Psychopharmacol 102: 291-294
5. Allard P, Rinne J, Marcusson JO (1994) Dopamine uptake sites in Parkinson's disease and in dementia of the Alzheimer type. Brain Res 637: 262-266
6. 3H]WIN 35,428 binding in the human brain. Brain Res 706: 347-350
7. 3H]GBR 12935 binding. Eur J Pharmacol 249: 125-131
8. American Psychiatric Association (1987) Diagnostic and statistical manual of mental disorders, 3rd edn revised (DSM-III-R). American Psychiatric Association, Washington DC
9. Baxter LR, Phelps ME, Mazziotta JC, Schwartz JM, Gerner RH, Selin CE, Sumida RM (1985) Cerebral metabolic rates for glucose in mood disorders. Arch Gen Psychiatry 42: 441-447
10. 18F]2-deoxyglucose in affective illness. J Affect Disord 10: 137-152
11. Clarke RL, Daum SJ, Gambino AJ, Aceto MD, Pearl J, Levitt M, Cumiskey WR, Bogado EF (1973) Compounds affecting the central nervous system. 4.3β-Phenyltropane-2-carboxylic esters and analogs. J Med Chem 16: 1260-1267
12. Cummings JL (1992) Depression and Parkinson's disease: a review. Am J Psychiatry 149: 443-454
13. D'haenen HA, Bossuyt A (1994) Dopamine D2 receptors in depression measured with single photon emission computed tomography. Biol Psychiatry 35: 128-132
14. 11C]β-CIT binding to monoamine transporters in the monkey and human brain. Synapse 16: 93-103
15. 3H]GBR-12935 binding sites in human striatal membranes: binding characteristics and changes in parkinsonians and schizophrenics. Jpn J Pharmacol 47: 237-243
16. 3H]GBR-12935 binding to the dopamine transporter is decreased in the caudate nucleus in Parkinson's disease. J Neurochem 49: 617-621
17. Kuniyoshi M, Arikawa K, Miura C, Inanaga K (1989) Parkinsonism manifesting depression as the first sign. Jpn J Psychiatr Neurol 43: 37-43
18. 3H]GBR-12935 binding to dopamine uptake sites: subcellular localization and reduction in Parkinson's disease and progressive supranuclear palsy. Eur J Pharmacol 156: 331-340
19. Narabayashi H (1985) Pharmacological treatment of Parkinson's disease-past and future. Jpn J Neuropsychopharmacol 7: 713-728
20. 3H]spiperone binding in the rat striatum. Cell Mol Neurobiol 12: 597-606
21. Pearce RKB, Seeman P, Jellinger K, Tourtellotte WW (1990) Dopamine uptake sites and dopamine receptors in Parkinson's disease and schizophrenia. Eur Neurol 30 [Suppl 1]: 9-14
22. Pirker W, Asenbaum S, Kasper S, Walter H, Angelberger P, Koch G, Pozzera A, Deecke L, Podreka I, Brücke T (1995) β-CIT SPECT demonstrates blockade of 5HT-uptake sites by citalopram in the human brain in vivo. J Neural Transm [Gen Sect] 100: 247-256
23. Pitchot W, Hansenne M, Gonzalez Moreno A, Ansseau M (1992) Suicidal behavior and growth hormone response to apomorphine test. Biol Psychiatry 31: 1213-1219
24. Roy A, Ågren H, Pickar D, Linnoila M, Doran AR, Cutler NR, Paul SM (1986) Reduced cerebrospinal fluid concentrations of homovanillic acid and homovanillic acid to 5-hydroxy-indoleacetic acid ratio in depressed patients: relationship to suicidality and dexamethasone nonsuppression. Am J Psychiatry 143: 1539-1545
25. Roy A, De Jung J, Linnoila M (1989) Cerebrospinal fluid monoamine metabolites and suicidal behavior in depressed patients. A 5 - year follow up. Arch Gen Psychiatry 46: 609-612
26. Suhara T, Nakayama K, Inoue O, Fukuda H, Shimizu M, Mori A, Tateno Y (1992) D1 dopamine receptor binding in mood disorders measured by positron emission tomography. Psychopharmacol 106: 14-18
27. Träskman L, Åsberg M, Bertilsson L, Sjöstrand L (1981) Monoamine metabolites in CSF and suicidal behavior. Arch Gen Psychiatry 38: 631-636
28. 3H]GBR 12783 in the striatum. Activ Nerv Super 31: 273-274